Hospital de Santa Maria MHM is a public Central Hospital serving the Greater Lisbon area as part of the Northern Lisbon University Hospital Centre, a State-owned enterprise. Santa Maria is the largest hospital in Lisbon and indeed in Portugal.

During the past decade, Hospital de Santa Maria; Servico de Neurologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital de Santa Maria; Servico de Neurologia" are "Alzheimer's Disease" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hospital de Santa Maria; Servico de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital de Santa Maria; Servico de Neurologia" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "Fenebrutinib" (2 trials), "Gantenerumab" (2 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Santa Maria; Servico de Neurologia" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Santa Maria; Servico de Neurologia". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital de Santa Maria; Servico de Neurologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Santa Maria; Servico de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".